Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Pr Bart LEROY

In this page

Member info

Pr Bart LEROY

Representative

Belgium

Working Group Leader: Retinal Rare Eye Diseases (WG1)
Other Working Group(s): Retinal Rare Eye Diseases (WG1), Low Vision Daily Life and Patients Groups (TWG5), Genetic Diagnostics (TWG6), Research (TWG8), National Integration (TWG9)

Team

Pr Elfride DE BAERE

Belgium

Genetic Diagnostics (TWG6), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

HCP Center

The Ghent University Hospital is one of the largest and most specialized hospitals in Flanders with more than 3,000 patients a day and more than...

contact

Ghent University Hospital, Ghent, Belgium

Corneel Heymanslaan 10
9000 Ghent
Belgium

Clinical trials

NCT04855045 Unknown

An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects G (p.Cys998X) Mutation.

Interventional
See the trial
voir la fiche
NCT05566795 Recruiting, Active

A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

Interventional
See the trial
voir la fiche

NCT04671433 Active, Not recruiting

Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT04794101 Active, Not recruiting

Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT04127006 Active, Not recruiting

Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).

Observational
See the trial
voir la fiche
NCT03913143 Active, Not recruiting

A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).

Interventional
See the trial
voir la fiche
NCT03293524 Active, Not recruiting

Efficacy & Safety Study of Bilateral Intravitreal Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year (REFLECT).

Interventional
See the trial
voir la fiche
NCT03140969 Completed

Study to Evaluate QR-110 in Subjects With Leber’s Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene.

Interventional
See the trial
voir la fiche
NCT03146078 Active, Not recruiting

Rate of Progression in USH2A Related Retinal Degeneration

Observational
See the trial
voir la fiche
NCT02796274 Completed

Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).

Interventional
See the trial
voir la fiche
NCT02544217 Completed

A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176.

Interventional
See the trial
voir la fiche
NCT04295304 Terminated

Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases

Interventional
See the trial
voir la fiche
NCT05811351 Recruiting, Active

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Interventional
See the trial
voir la fiche
NCT05436665 Recruiting, Active

The Belgian Endothelial Surgical Transplant of the Cornea:Clinical and Patient-reported Outcomes of Descemet Stripping Automated Endothelial Keratoplasty(DSAEK) Versus Descemet Membrane Endothelial Keratoplasty(DMEK)

Interventional
See the trial
voir la fiche
NCT06294613 Recruiting, Active

A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Interventional
See the trial
voir la fiche
NCT00481546 Active, Not recruiting

Phase I Trial of Gene Vector to Patients with Retinal Disease due toRPE65 mutations

Interventional
See the trial
voir la fiche
NCT03992417 Active, Not recruiting

A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis

Observational
See the trial
voir la fiche

Scientific publications

Hydroxychloroquine hitting the headlines – retinal considerations

In this editorial, we highlight the importance of careful use of these drugs, because of their potential to cause an irreversible toxic...

Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F‐mediated inherited retinal disorders

A comprehensive study applying direct Sanger sequencing of the gene‐coding regions, exome and genome sequencing applied to a large cohort of...

The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement

ERN-EYE promotes access to genetic testing in RED and emphasizes the clinical need and relevance of genetic testing in...

Phenocopy of a heterozygous carrier of X-linked retinitis pigmentosa due to mosaicism for a RHO variant

We describe both phenotype and pathogenesis in two male siblings with typical retinitis pigmentosa (RP) and the potentially X-linked RP (XLRP)...

Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia

We provide extensive in silico analyses and summarize reported functional data of previously analyzed missense, nonsense and splicing variants to...

Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy

Van de Sompele et al. used multiomics profiling and in vitro and in vivo enhancer assays to dissect the regulatory mechanisms underlying North...

Novel Clinical Observations and Genetic Spectrum in 340 Patients

In most patients, XLRS showed a slow deterioration starting in the second decade of life, suggesting an optimal window of opportunity for...

Optic nerve involvement in CACNA1F-related disease: observations from a multicentric case series

Our data support the hypothesis that CACNA1F could be related to early-onset or congenital optic nerve involvement without any signs of a...

Outcome of Cataract Surgery in Patients With Retinitis Pigmentosa

To assess the visual outcome of cataract surgery in patients with retinitis pigmentosa...

RNA-based therapies in inherited retinal diseases

This review will examine the increasing breadth and relevance of RNA-based therapies in clinical medicine, explore the key features that make AONs...

The Natural History of Leber Congenital Amaurosis and ConeeRod Dystrophy Associated with Variants in the GUCY2D Gene

Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy...

Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis

Here, we present the outcome for 1,192 probands that underwent smMIPs-based sequencing using the RP-LCA smMIPs...

PDF - 1 MB

Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis

Our data indicate that treatment with (oral) CAI may be beneficial for short-term management of CFC in patients with...

Analysis of KERA in four families with cornea plana identifies two novel mutations

To identify the molecular genetic cause in four families of various ethnic backgrounds with cornea...

Long-Term Follow-Up of Retinal Degenerations Associated With LRAT Mutations and Their Comparability to Phenotypes Associated With RPE65 Mutations

To investigate the natural history in patients with LRAT-associated retinal degenerations (RDs), in the advent of clinical trials testing...

Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect

Ten patients with Leber congenital amaurosis carrying the c.2991+1655A>G allele in the ciliopathy gene centrosomal protein 290 (CEP290) were...